Cited 7 times in
Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.